Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06754150 · ClinicalTrials.gov registry record

Shoulder Innovations Clinical Data Registry

A clinical trial of Shoulder Arthroplasty, sponsored by Shoulder Innovations.

Recruiting
Registry status
2,500
Enrollment target
6
Study locations

NCT06754150: Recruiting study of Shoulder Arthroplasty, sponsored by Shoulder Innovations.

NCT06754150 is a study of Shoulder Arthroplasty that is actively recruiting participants, run by Shoulder Innovations. The registered enrollment target is 2,500 participants, above the 606-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (313% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06754150, a study of Shoulder Arthroplasty, is actively recruiting participants, sponsored by Shoulder Innovations.

RECRUITING
Registry status
2,500 participants
Enrollment target
6
Study locations

Study Summary

The goal of this multi-center observational study is to collect long-term clinical outcome information for anatomic and reverse total shoulder arthroplasty (shoulder replacement).

Primary Outcome

Assessment of the SI device component will be made at specified intervals using x-rays to check how long the device component can stay implanted with or without a revision surgery.

Conditions Studied

Study Locations (6)

Alabama

  • St. Vincent's Orthopedics - Birmingham

California

  • California Pacific Orthopaedics - San Francisco

Colorado

  • Western Orthopaedics - Denver

Florida

  • Connolly Orthopedics - Bradenton

Georgia

  • Georgia Bone and Joint - Newnan

Massachusetts

  • North Shore Physicians Group - Peabody

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2024-10-23
Est. Completion 2039-12
Shoulder Innovations

1 total trials

What NCT06754150 shows while recruiting

NCT06754150 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 606-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (313% higher).

The record links to 1 condition, with Shoulder Arthroplasty appearing as the primary indexed condition, and to 0 interventions.

NCT06754150 lists 6 locations in 6 states (Alabama, California, Colorado).

Frequently Asked Questions

What is clinical trial NCT06754150 about?

NCT06754150 is a clinical study titled "Shoulder Innovations Clinical Data Registry". The goal of this multi-center observational study is to collect long-term clinical outcome information for anatomic and reverse total shoulder arthroplasty (shoulder replacement).

What is the current status of trial NCT06754150?

This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2024-10-23. Estimated completion is 2039-12.

What conditions does trial NCT06754150 study?

This clinical trial studies the following conditions: Shoulder Arthroplasty.

Who is sponsoring clinical trial NCT06754150?

This trial is sponsored by Shoulder Innovations, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06754150 being conducted?

This trial has 6 study locations across Alabama, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06754150, the US trial registry maintained by the National Library of Medicine. NCT06754150 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.